| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/2011 | CN102079780A Construction of recin A chain mutant and application of recin A chain mutant as candidate vaccine antigen |
| 06/01/2011 | CN102079779A Soybean GmFTL1 protein and soybean GmFTL2 protein as well as applications thereof |
| 06/01/2011 | CN102079778A Antibacterial protein and preparation method and application thereof |
| 06/01/2011 | CN101353379B Protein modified biological-inorganic nano composite material and preparation thereof |
| 06/01/2011 | CN101323641B Anti-opioid peptide, antagonistic peptide thereof and use thereof |
| 06/01/2011 | CN101230334B Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 06/01/2011 | CN101210046B Antifungal protein and usage thereof |
| 06/01/2011 | CN101104638B Solid phase synthetic technique for thymosin alpha1 |
| 05/31/2011 | US7951959 Hydrophilic labels for biomolecules |
| 05/31/2011 | US7951933 Adenosine triphophate-ribosylcyclase for identifying modulators to prevent and treat autoimmune, skin and inflammatory disorders |
| 05/31/2011 | US7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits |
| 05/31/2011 | US7951930 Cultured Xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
| 05/31/2011 | US7951929 Insecticidal compounds and methods for selection thereof |
| 05/31/2011 | US7951923 Fluorescent proteins and chromoproteins from non-Aequorea hydrozoa species and methods for using same |
| 05/31/2011 | US7951919 TACI-immunoglobulin fusion proteins |
| 05/31/2011 | US7951916 Il-1 related polypeptides |
| 05/31/2011 | US7951914 Genetically modified cyclic-nucleotide controlled ion channels |
| 05/31/2011 | US7951910 Peptides with the marburg I polymorphism of factor VII-activating protease (FSAP) and their preparation and uses |
| 05/31/2011 | US7951909 A polypeptide containing an N-terminal fragment of Amyloid beta (A beta ) peptide linked to a helper T cell epitope (Th) having multiple class II binding motifs; generated antibodies are highly cross-reactive to the soluble A beta 1-42 peptide and the amyloid plaques in the brain |
| 05/31/2011 | US7951908 Recombinant spider silk proteins |
| 05/31/2011 | US7951907 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/31/2011 | US7951783 Therapeutically useful molecules |
| 05/31/2011 | US7951781 Methods and compositions related to PLUNC surfactant polypeptides |
| 05/31/2011 | US7951778 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/31/2011 | US7951777 administering one or more of vasoactive intestinal peptide (VIP) and active fragment(s) fortherapeutic treatment of myocardial fibrosis or an associated condition in a patient |
| 05/31/2011 | US7951776 Methods for treatment of type 1 diabetes |
| 05/31/2011 | US7951771 Activin-ActRIIa antagonists and uses for promoting bone growth |
| 05/31/2011 | US7951595 Methods for screening modulators of SLC17-type anion transport activity |
| 05/31/2011 | US7951589 Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 05/31/2011 | US7951588 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 05/31/2011 | US7951586 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 05/31/2011 | US7951565 Process for the production of fine chemicals |
| 05/31/2011 | US7951562 Method for glycosylating hydroxylysine residues in polypeptides or peptides |
| 05/31/2011 | US7951559 Recombinant peptide production using a cross-linkable solubility tag |
| 05/31/2011 | US7951552 Method of preparing non-human tissues for xenotransplantation using α-galactosidase |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951532 Modulating mammalian midkine activity; alters pulmonary vasculature development and smooth muscle cell development |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951381 Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor |
| 05/31/2011 | US7951380 Methods of stimulating bone growth using ZVEGF4 polypeptides |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders |
| 05/31/2011 | US7951376 Multimeric complexes of antigens and an adjuvant |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951373 Administering to mammal a neural growth and/or remyelination and/or neuroprotection promoting amount of an agent comprising a neural cell adhesion molecule, which molecule is capable of overcoming inhibitory molecular cues found on glial cells |
| 05/31/2011 | US7951372 Method of treating psoriasis by administering IL-22 antibodies, or binding fragments thereof |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | US7951361 Transgenic escherichia for which express bacterial surface protein for use in generation of vaccine which prevents coliform bacterial infection; antidiarrhea agents |
| 05/31/2011 | US7951360 Mutant interleukin-2 (IL-2) polypeptides |
| 05/31/2011 | US7951357 Implantable power sources and sensors |
| 05/31/2011 | US7951210 Support-colouring means |
| 05/31/2011 | CA2588581C Detection of nucleic acids from multiple types of human papillomaviruses |
| 05/31/2011 | CA2539168C Optimized expression of hpv 45 l1 in yeast |
| 05/31/2011 | CA2465054C Aequorin as a growth marker in yeast |
| 05/31/2011 | CA2441357C Agent for the prevention and treatment of sexually transmitted diseases-i |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/31/2011 | CA2323064C Nucleic acid binding proteins |
| 05/31/2011 | CA2301942C Molecular mimetics of meningococcal b epitopes |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/31/2011 | CA2215328C Novel human cytomegalovirus dna sequences |
| 05/26/2011 | WO2011063320A2 Recombinant filaggrin polypeptides for cell importation |
| 05/26/2011 | WO2011063283A2 Methods for detecting a mycobacterium tuberculosis infection |
| 05/26/2011 | WO2011063277A1 Anti-orai1 antigen binding proteins and uses thereof |
| 05/26/2011 | WO2011063275A1 Suppression of cancer metastasis |
| 05/26/2011 | WO2011063235A2 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 05/26/2011 | WO2011063195A2 Purification of modified cytokines |
| 05/26/2011 | WO2011063165A1 Methods and compositions for capture of cells |
| 05/26/2011 | WO2011063009A1 Methods, devices, kits and compositions for detecting roundworm |
| 05/26/2011 | WO2011063003A2 Peptides and methods for the detection of lyme disease antibodies |
| 05/26/2011 | WO2011062935A1 Compositions and assay systems for intracellular processes |
| 05/26/2011 | WO2011062748A1 Sucrose transporter genes for increasing plant seed lipids |
| 05/26/2011 | WO2011062637A1 Enhanced malaria msp-1 subunit vaccine |
| 05/26/2011 | WO2011062561A1 The isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair. |
| 05/26/2011 | WO2011062354A2 Method for preparing gintonin, which is a novel glycolipoprotein from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method |
| 05/26/2011 | WO2011061705A1 Method for treating blood plasma including a step of washing by means of dispersion |
| 05/26/2011 | WO2011061700A2 Ifnϒ inhibitors in the treatment of motoneuron diseases |
| 05/26/2011 | WO2011061625A2 Compositions for increasing polypeptide stability and activity, and related methods |
| 05/26/2011 | WO2011061194A1 Inhibitors of centrosomal clustering |
| 05/26/2011 | WO2011060950A1 Screening method for active substances used for the prevention and treatment of neurodegenerative diseases |
| 05/26/2011 | WO2011060613A1 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
| 05/26/2011 | WO2011060583A1 Nonnatural collagen-like protein and use thereof |
| 05/26/2011 | WO2011060552A1 Variegation in plants |
| 05/26/2011 | WO2011060534A1 Trim5alpha mutants and uses thereof |
| 05/26/2011 | WO2011039639A3 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 05/26/2011 | WO2011039584A3 Parstatin peptides |
| 05/26/2011 | WO2010144711A3 Immunological targeting of pathological tau proteins |
| 05/26/2011 | WO2010136031A9 Fibroblast growth factor receptor-derived peptides binding to ncam |
| 05/26/2011 | WO2010120541A3 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 05/26/2011 | WO2010105097A8 Sparc angiogenic domain and methods of use |
| 05/26/2011 | US20110126326 Strong activation domain |
| 05/26/2011 | US20110126318 Sucrose transporter genes for increasing plant seed lipids |
| 05/26/2011 | US20110126317 Plant viral expression vectors and use of same for generating genotypic variations in plant genomes |
| 05/26/2011 | US20110126314 Modulation of coffee flavour precursor levels in green coffee grains |
| 05/26/2011 | US20110126305 Mutant blue fluorescent protein and method of using the same for fluorescence resonance energy transfer and blue fluorescent fish |
| 05/26/2011 | US20110126303 Modified Blood Clotting Factors And Methods Of Use |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110125089 Hemostatic microspheres |